GATA2 deficiency spectrum
Learn about GATA2 deficiency spectrum, its reported features, relevant specialists, and questions to discuss at a medical consultation.
Also known as: GATA binding protein 2 deficiency spectrum
The sources compiled here do not cover: diagnosis, treatment, prevention, prognosis. Ask the treating doctor about these.
What it is
From: Orphanet
A rare genetic primary immunodeficiency characterized by profound circulating monocytopenia, B- and NK-cell lymphopenia and severe dentritic cell decrease, which manifests clinically with disseminated mycobacterial and viral infections, as well as opportunistic fungal and parasitic infections and frequent pulmonary alveolar proteinosis. Predisposition to developping myeloid neoplasms is associated.
Reported clinical features and what the terms mean
The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.
The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.
- Abnormal neutrophil count · Very frequent (99-80%)
- A deviation from the normal range of neutrophil cell counts in the circulation.
- Abnormality of speech or vocalization · Very frequent (99-80%)
- An abnormality in the sound (volume) or cadence (rate) of speech.
- Acute leukemia · Very frequent (99-80%)
- A clonal (malignant) hematopoietic disorder with an acute onset, affecting the bone marrow and the peripheral blood. The malignant cells show minimal differentiation and are called blasts, either myeloid blasts (myeloblasts) or lymphoid blasts (lymphoblasts).
- Bone marrow hypocellularity · Very frequent (99-80%)
- A reduced number of hematopoietic cells present in the bone marrow relative to marrow fat.
- Fatigue · Very frequent (99-80%)
- A subjective feeling of tiredness characterized by a lack of energy and motivation.
- Lymphedema · Very frequent (99-80%)
- Localized fluid retention and tissue swelling caused by a compromised lymphatic system.
- Prolonged bleeding time · Very frequent (99-80%)
- Prolongation of the time taken for a standardized skin cut of fixed depth and length to stop bleeding.
- Respiratory failure · Very frequent (99-80%)
- A severe form of respiratory insufficiency characterized by inadequate gas exchange such that the levels of oxygen or carbon dioxide cannot be maintained within normal limits.
- Sensorineural hearing impairment · Very frequent (99-80%)
- A type of hearing impairment in one or both ears related to an abnormal functionality of the cochlear nerve.
- Thrombocytopenia · Very frequent (99-80%)
- A reduction in the number of circulating thrombocytes.
- Abnormal optic nerve morphology · Frequent (79-30%)
- Abnormality of the optic nerve.
- Bruising susceptibility · Frequent (79-30%)
- An ecchymosis (bruise) refers to the skin discoloration caused by the escape of blood into the tissues from ruptured blood vessels. This term refers to an abnormally increased susceptibility to bruising. The corresponding phenotypic abnormality is generally elicited on medical history as a report of frequent ecchymoses or bruising without adequate trauma.
- Chronic otitis media · Frequent (79-30%)
- Chronic otitis media refers to fluid, swelling, or infection of the middle ear that does not heal and may cause permanent damage to the ear.
- Fever · Frequent (79-30%)
- Body temperature elevated above the normal range.
Other findings in the same source
From: Orphanet
Additional reported features include Hepatomegaly (Frequent (79-30%)); Hypercoagulability (Frequent (79-30%)); Intracranial hemorrhage (Frequent (79-30%)); Migraine (Frequent (79-30%)); Nausea and vomiting (Frequent (79-30%)); Pallor (Frequent (79-30%)); Recurrent respiratory infections (Frequent (79-30%)); Splenomegaly (Frequent (79-30%)); Vertigo (Frequent (79-30%)); Visual loss (Frequent (79-30%)). This is a selected summary, not a complete description of the condition.
When it may begin
From: Orphanet
Adult
Inheritance in the source
From: Orphanet
Autosomal dominant; Not applicable
Frequency and the population described
From: Orphanet
Reported case(s): 22.0; Worldwide. This is a published case count, not prevalence. Point prevalence: <1 / 1 000 000; Worldwide; Class only.
Which doctor should you see?
The suggested department for discussing GATA2 deficiency spectrum is Allergy and Immunology, with a allergist / clinical immunologist as the relevant type of clinician. General physician / Family Medicine; paediatrician for children. Referral depends on symptoms.
Additional services that may be relevant, depending on the findings, include: Clinical Genetics.
This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.
How to prepare for an assessment
Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.
Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.
- Does the history suggest an allergy, an immune problem or another explanation?
- How would any proposed allergy or immune test change care?
- Is an individual emergency plan needed, and who should understand it?
Treatment discussions and follow-up
The material gathered for this draft does not provide a complete condition-specific treatment pathway for GATA2 deficiency spectrum. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.
Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.
The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.
When to seek emergency help
Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.
Allergy and Immunology is not listed separately on The Doctor Index; the nearest speciality is internal medicine. Every profile shows the doctor’s registration and what has been checked.
All allergy and immunology conditions →
Sources
- Orphanet — GATA2 deficiency spectrum — Orphadata Science, CC BY 4.0
- Human Phenotype Ontology Consortium — terminology definitions — HPO licence; definitions reproduced without alteration
- Government of India — Emergency Response Support System — Official reference for India emergency number
Source: MedlinePlus, National Library of Medicine. Orphadata Science: Free access data from Orphanet. © INSERM 1999; July 2026 data, CC BY 4.0. This product uses the Human Phenotype Ontology (hp/releases/2026-09-01). Only sources listed for this article apply. Source material has been selected and arranged; HPO definitions are reproduced without alteration. No source organisation endorses this compilation. Köhler S et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Research 2014;42(D1):D966–D974. doi:10.1093/nar/gkt1026.
General information, not advice about your situation. Errors can be reported through the corrections process. Reference TDI-C-0989.